The makers of a new COVID-19 vaccine say it shows 100% efficacy so far at preventing severe disease and hospitalization.
Pharmaceutical firms Sanofi and GSK are now planning to submit the vaccine to American and European regulatory authorities.
Ira Spitzer has more.
IN: The 2-dose vaccine...